130 related articles for article (PubMed ID: 20692076)
1. [Malignant phyllodes tumor of the breast with lymph node metastases shown by FDG PET-CT].
Santiago Chinchilla A; Ramos Font C; Custodio Rebollo Aguirre A; Navarro-Pelayo Láinez M; Palacios Gerona H; Llamas Elvira JM
Rev Esp Med Nucl; 2010; 29(6):314-5. PubMed ID: 20692076
[No Abstract] [Full Text] [Related]
2. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
Hathaway PB; Mankoff DA; Maravilla KR; Austin-Seymour MM; Ellis GK; Gralow JR; Cortese AA; Hayes CE; Moe RE
Radiology; 1999 Mar; 210(3):807-14. PubMed ID: 10207485
[TBL] [Abstract][Full Text] [Related]
3. Primary epithelioid trophoblastic tumor with a synchronous breast carcinoma detected only with FDG-PET/CT Scan.
Kara T; Ozcan Kara P; Baba F; Celik C; Kara Gedik G
Rev Esp Med Nucl; 2011; 30(6):368-71. PubMed ID: 21440960
[TBL] [Abstract][Full Text] [Related]
4. Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.
Adler LP; Faulhaber PF; Schnur KC; Al-Kasi NL; Shenk RR
Radiology; 1997 May; 203(2):323-7. PubMed ID: 9114082
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
[TBL] [Abstract][Full Text] [Related]
6. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data.
Carkaci S; Macapinlac HA; Cristofanilli M; Mawlawi O; Rohren E; Gonzalez Angulo AM; Dawood S; Resetkova E; Le-Petross HT; Yang WT
J Nucl Med; 2009 Feb; 50(2):231-8. PubMed ID: 19164229
[TBL] [Abstract][Full Text] [Related]
7. Should FDG PET/CT be used for the initial staging of breast cancer?
Groheux D; Hindié E; Rubello D; Espié M; Baillet G; Giacchetti S; Misset JL; Moretti JL
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1539-42. PubMed ID: 19449002
[No Abstract] [Full Text] [Related]
8. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
Yutani K; Tatsumi M; Shiba E; Kusuoka H; Nishimura T
J Nucl Med; 1999 Jun; 40(6):1003-8. PubMed ID: 10452318
[TBL] [Abstract][Full Text] [Related]
9. A pulmonary metastasis of a cystosarcoma phyllodes of the breast detected by 18F-FDG PET/CT.
Treglia G; Muoio B; Caldarella C; Parapatt GK
Clin Nucl Med; 2014 Mar; 39(3):e233-5. PubMed ID: 23603592
[TBL] [Abstract][Full Text] [Related]
10. Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging.
Taira N; Ohsumi S; Takabatake D; Hara F; Takashima S; Aogi K; Takashima S; Inoue T; Sugata S; Nishimura R
Jpn J Clin Oncol; 2009 Jan; 39(1):16-21. PubMed ID: 18997183
[TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer.
Gil-Rendo A; Zornoza G; García-Velloso MJ; Regueira FM; Beorlegui C; Cervera M
Br J Surg; 2006 Jun; 93(6):707-12. PubMed ID: 16622900
[TBL] [Abstract][Full Text] [Related]
12. F-18 FDG whole-body positron emission tomography scan in primary breast sarcoma.
Bakheet SM; Powe J; Ezzat A; Al Suhaibani H; Tulbah A; Rostom A
Clin Nucl Med; 1998 Sep; 23(9):604-8. PubMed ID: 9735983
[TBL] [Abstract][Full Text] [Related]
13. [FDG-PET (positron emission tomography) in the detection of primary breast cancer and lymph node involvement].
Koga S; Nakano S; Honma Y; Ogasawara N
Nihon Rinsho; 2007 Jun; 65 Suppl 6():379-84. PubMed ID: 17682181
[No Abstract] [Full Text] [Related]
14. Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
Aukema TS; Straver ME; Peeters MJ; Russell NS; Gilhuijs KG; Vogel WV; Rutgers EJ; Olmos RA
Eur J Cancer; 2010 Dec; 46(18):3205-10. PubMed ID: 20719497
[TBL] [Abstract][Full Text] [Related]
15. PET imaging in breast cancer.
Bombardieri E; Crippa F
Q J Nucl Med; 2001 Sep; 45(3):245-56. PubMed ID: 11788817
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer staging in a single session: whole-body PET/CT mammography.
Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
[TBL] [Abstract][Full Text] [Related]
17. Occult breast primary malignancy presenting as isolated axillary lymph node metastasis - early detection of primary site by 18F-FDG PET/CT.
Soundararajan R; Naswa N; Karunanithi S; Walia R; Kumar R; Bal C
Nucl Med Rev Cent East Eur; 2016; 19(B):5-7. PubMed ID: 27813620
[TBL] [Abstract][Full Text] [Related]
18. Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group.
Wahl RL; Siegel BA; Coleman RE; Gatsonis CG;
J Clin Oncol; 2004 Jan; 22(2):277-85. PubMed ID: 14722036
[TBL] [Abstract][Full Text] [Related]
19. [The role of preoperative investigation with 18-FDG-PET/CT in primary operable breast cancer].
Garami Z; Hascsi Z; Garai I; Tanyi M; Lukács G; Damjanovich L
Magy Seb; 2009 Jun; 62(3):107-12. PubMed ID: 19525175
[TBL] [Abstract][Full Text] [Related]
20. Rare Case of Phyllodes Tumor of Breast with Cardiac and Pancreatic Metastases: Findings on
Singh P; Parida GK; Singhal T; Kumar P; Bishnoi K; Agrawal K
J Nucl Med Technol; 2023 Jun; 51(2):156-157. PubMed ID: 36750379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]